Institutional Ownership
Indaptus Therapeutics Inc
CUSIP 45339J204COM NEWINDPQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
6
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Citadel Advisors LLC | 39.0K | $71.0K |
| 2 | Geode Capital Management, LLC | 27.0K | $49.2K |
| 3 | Morgan Stanley | 2.7K | $4.9K |
| 4 | Tower Research Capital LLC (Trc) | 1.9K | $3.4K |
| 5 | Sbi Securities Co., Ltd. | 17 | $31 |
| 6 | Cwm, LLC | 2 | $4 |